FDA Inspection 1155778 - Rhode Island Blood Center a Divison of New York Blood Center Inc - October 27, 2021
FDA Inspection 1155778 for Rhode Island Blood Center a Divison of New York Blood Center Inc on October 27, 2021. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1155778 for Rhode Island Blood Center a Divison of New York Blood Center Inc on October 27, 2021. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
October 27, 2021
Product Type
Biologics
ID: fd4408bf-9547-4682-8993-5ac444ef25e7
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox